What to test before starting TRT
Baseline blood work is your TRT safety net. Without knowing your starting values, you cannot track changes, adjust doses, or catch problems early. Testing before TRT also establishes medical necessity for insurance coverage and legal prescription requirements.
Essential hormone markers include total testosterone (measured twice in morning fasting draws), free testosterone, sex hormone-binding globulin (SHBG), luteinizing hormone (LH), follicle-stimulating hormone (FSH), and estradiol. Total testosterone below 300 ng/dL combined with symptoms typically qualifies for TRT. Free testosterone shows what is actually available to tissues since SHBG binds and inactivates much circulating testosterone.
Safety monitoring markers are equally important. Complete blood count (CBC) tracks red blood cell production before testosterone stimulates it. Hematocrit and hemoglobin levels establish your baseline before potential elevation. Prostate-specific antigen (PSA) rules out existing prostate issues and provides a reference point for future monitoring. Comprehensive metabolic panel checks liver and kidney function, while lipid panel establishes cardiovascular risk factors.
Thyroid function affects testosterone levels and TRT response. Test TSH, free T3, and free T4 since thyroid disorders can mimic low testosterone symptoms. Many men with "low T" actually have undiagnosed thyroid problems. Additionally, vitamin D, B12, and iron levels can affect energy, mood, and overall response to TRT. These tests cost approximately $400-600 out of pocket or $150-300 with insurance.
What each number means in plain English
Total testosterone measures all testosterone in your blood, both bound and free. Normal lab range runs 250-800 ng/dL, but optimal for most men is 600-1000 ng/dL. Values below 300 ng/dL typically indicate hypogonadism. Above 1200 ng/dL suggests excessive dosing. Your goal is the upper half of normal range with symptom resolution, not maximum levels.
Free testosterone shows hormone actually available to tissues since most testosterone binds to proteins. Normal range is 46-224 pg/mL, optimal is typically above 100 pg/mL. Low free testosterone with normal total testosterone indicates high SHBG binding. Free testosterone correlates better with symptoms than total testosterone in many men. Direct measurement is more accurate than calculated estimates.
Sex hormone-binding globulin (SHBG) binds and inactivates testosterone. Normal range is 10-80 nmol/L. High SHBG (above 60) reduces free testosterone despite normal total levels. Low SHBG (below 20) can cause rapid testosterone clearance and mood swings. SHBG decreases with age, obesity, and insulin resistance. It increases with thyroid disorders and liver disease.
Estradiol (E2) results from testosterone conversion via aromatase enzyme. Normal male range is 10-40 pg/mL, optimal for TRT is typically 20-35 pg/mL. Below 15 pg/mL causes joint pain, low libido, and mood issues despite adequate testosterone. Above 40 pg/mL causes water retention, emotional swings, and potential gynecomastia. Use sensitive assay testing, not standard estradiol tests designed for women.
Hematocrit and hemoglobin measure red blood cell concentration. Normal hematocrit ranges 38-50%, hemoglobin 13.5-16.5 g/dL. TRT commonly elevates these values. Hematocrit above 54% or hemoglobin above 18 g/dL increases stroke and heart attack risk through blood thickening. Regular blood donations or dose adjustments may be necessary when levels climb too high.
Prostate-specific antigen (PSA) screens for prostate problems. Normal is below 4.0 ng/mL for men under 60, below 5.0 for older men. Values above 10 ng/mL warrant immediate urological evaluation. More concerning than absolute values is rapid rise: PSA doubling in less than 12 months suggests potential prostate issues requiring investigation regardless of absolute value.
When to retest and why timing matters
TRT monitoring follows a specific schedule tied to testosterone pharmacokinetics and physiological adaptation timelines. Baseline testing occurs before first injection, establishing your natural hormone profile and ruling out contraindications to TRT. This includes all hormones, safety markers, and general health panels discussed above.
Six-week follow-up captures initial adaptation to exogenous testosterone. Testosterone cypionate reaches steady-state levels after 4-5 half-lives, approximately 35-40 days. Testing at 6 weeks shows whether dosing achieves target levels and reveals early side effects like hematocrit elevation or estrogen imbalance. Adjust dose and frequency based on these results.
Three-month monitoring assesses full adaptation to your protocol. All physiological systems have adjusted to exogenous testosterone by this point. PSA levels stabilize, body composition changes become apparent, and symptom resolution peaks. This timing guides long-term protocol decisions and identifies any delayed side effects requiring intervention.
Six-month and annual testing monitor long-term safety and effectiveness. Check all baseline markers annually, with testosterone, estradiol, and hematocrit every 6 months if stable. Men with risk factors may require quarterly monitoring. PSA should be checked annually in men over 40 or with family history of prostate cancer.
Trough versus peak testing significantly affects interpretation. Trough levels (just before next injection) show your lowest testosterone while peak levels (24-48 hours post-injection) show your highest. Most physicians prefer trough testing for consistency, but peak testing may be necessary if symptoms occur despite adequate trough levels. Document injection timing on lab requisitions. For daily protocols, any time is acceptable since levels remain stable.
Red flags that require immediate attention
Hematocrit above 54% or hemoglobin above 18 g/dL creates dangerous blood viscosity. Symptoms include headaches, dizziness, blurred vision, and increased stroke risk. Immediate interventions include dose reduction, blood donation, or temporary TRT discontinuation. Some men require phlebotomy every 8-12 weeks to maintain safe levels. Consider switching to smaller, more frequent doses to reduce erythropoietin stimulation.
PSA doubling within 12 months warrants urological evaluation regardless of absolute value. While TRT does not cause prostate cancer, it can accelerate existing disease. A rise from 1.0 to 2.0 ng/mL concerns physicians more than a stable 3.5 ng/mL reading. Annual digital rectal exams supplement PSA monitoring. Men with family history require more frequent screening.
Estradiol climbing unchecked above 50 pg/mL causes multiple problems. Water retention adds 5-10 pounds within weeks. Gynecomastia development feels like tender lumps behind nipples. Emotional swings include depression, anxiety, and irritability despite good testosterone levels. Libido often decreases paradoxically. Address through dose reduction, injection frequency increase, or aromatase inhibitor consideration.
Liver enzymes (ALT/AST) elevated above twice normal range suggest hepatotoxicity, though rare with injectable testosterone. Oral testosterone preparations pose greater liver risk. Other causes include alcohol, medications, or fatty liver disease. Discontinue TRT temporarily while investigating causes. Most liver enzyme elevations resolve with cessation.
Signs of polycythemia extend beyond lab values to physical symptoms. Facial flushing, particularly after exercise or alcohol, suggests increased red blood cell mass. Frequent nosebleeds, headaches, and vision changes require immediate evaluation. Blood pressure may increase from hyperviscosity. These symptoms combined with elevated hematocrit indicate dangerous polycythemia requiring urgent intervention.
How to read your Quest or LabCorp results
Laboratory results pages follow standardized formats but understanding the difference between reference ranges and optimal ranges is critical for TRT success. Reference ranges represent the middle 95% of test results from the general population, including unhealthy individuals. These ranges are too broad for optimizing hormone therapy.
On your results page, look for the actual value, reference range, and any flags. Normal testosterone might show "450 ng/dL (250-800)" with no flag, but this represents below-optimal levels for many men. The reference range includes 80-year-olds and men with metabolic disease, skewing values downward. TRT aims for optimal health, not population average.
Quest Diagnostics results typically show your value in the left column, reference range in parentheses, and flags like "H" (high) or "L" (low) to the right. Pay attention to collection time and fasting status. Testosterone must be drawn fasting before 10 AM for accuracy. Female reference ranges occasionally appear by mistake, showing dramatically different normal values.
LabCorp formatting places your result first, followed by reference range and units. Critical values receive phone calls, but borderline abnormal values may only show flags. Both labs flag values outside reference ranges, but normal does not mean optimal. A hematocrit of 48% receives no flag but may be too high for some TRT patients prone to polycythemia.
Optimal ranges for TRT differ significantly from reference ranges. Target total testosterone 700-1000 ng/dL (not 250-800). Free testosterone should exceed 100 pg/mL (not just 46-224). Estradiol works best at 20-30 pg/mL using sensitive assay (not 10-40). Hematocrit stays safest below 50% (not the lab's 50-52% upper limit). Always compare your results to TRT-specific optimal ranges, not population reference ranges.
Key takeaways
- Baseline testing before TRT is mandatory for safety and legal prescription requirements
- Follow the 6-week, 3-month, 6-month, then annual testing schedule religiously
- Trough testing (just before injection) provides the most consistent monitoring
- Hematocrit above 54% requires immediate intervention through dose reduction or blood donation
- PSA doubling within 12 months demands urological evaluation regardless of absolute value
- Estradiol above 40 pg/mL using sensitive assay causes multiple side effects requiring correction
- Reference ranges represent population averages, not optimal values for TRT patients
- Free testosterone correlates better with symptoms than total testosterone in many men
- Morning fasting draws before 10 AM ensure accurate testosterone measurement
- Track trends over time rather than focusing on single abnormal results
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide protocol.